GlaxoSmithKline PLC (GSK)
Symbol Info
Listed Symbol GSK
Name GlaxoSmithKline PLC
Share Info
Annual Info
Latest Fiscal Dividend Per Share $2.05
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $39,256,676,879
Latest Fiscal EPS $1.86
Price Info
21 Day Moving Average $40.9033
21 Day EMA $40.610640
50 Day Moving Average $40.6412
50 Day EMA $40.551890
200 Day EMA $39.636250
200 Day Moving Average 39.454610
52 Week High $42.47
52 Week Low $36.41
52 Week Change $2.304500
Alpha -0.002762
Beta 0.7141
Standard Deviation 0.048070
R2 0.265683
Periods 60
Share Information
10 Day Average Volume 2,388,698
20 Day Average Volume 2,477,781
30 Day Average Volume 2,543,574
50 Day Average Volume 2,411,889
Outstanding Shares 2,494,211,892
Float Shares 2,494,211,892
Percent Float 100.00%
Short Interest 6,044,207
Short Percent Float 0.20%
Short Interest Ratio 2.39
Short Date 2019-07-31
Holders
Institutions 974
Institute Holdings Date 2019-07-31
Institute Bought Previous 3 Months 16,890,684
Institute Holdings Percent 12.700000
Institute Sold Previous 3 Months 14,655,153
Insider Holdings Date
Insider Bought Previous 3 Months -
Insider Holdings Percent -
Insider Sold Previous 3 Months -
Insiders Shares Owned -
Price Change
7 Day Price Change $-0.2800026
7 Day Percent Change -0.69%
21 Day Price Change $-1.7200012
21 Day Percent Change -4.10%
30 Day Price Change $-0.9900017
30 Day Percent Change -2.40%
Month To Date Price Change $-1.09
Month To Date Percent -2.64%
90 Day Price Change $0.849999
90 Day Percent Change 2.16%
Quarter To Date $0.169998
Quarter To Date Percent 0.42%
180 Day Price Change $0.035690
180 Day Percent Change 0.09%
200 Day Price Change $2.761974
200 Day Percent Change 7.38%
Year To Date $2.985920
Year To Date Percent 8.03%
Profile
Description In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory and antiviral, as well as vaccines and consumer healthcare products. Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products.
Details
Issue Type CS
Market Cap $100,242,375,939
Sec Type DR
Auditor
Total Shares Outstanding 4,988,423,784
CEO Emma N Walmsley
Employees 113,245
Last Audit
Classification
CIK 0001131399
Industry Drug Manufacturers
Sector Healthcare
NAICS
Info
Address 980 Great West Road
Brentford, Middlesex TW8 9GS
Website http://www.gsk.com
Facisimile +44 2080477807
Telephone +44 2080475000
Email company.secretary@gsk.com
Key Ratios
Profitability
EBIT Margin 20.30
EBITDA Margin 30.2
Pre-Tax Profit Margin 18.2
Profit Margin Cont 15.26
Gross Margin 65.60
Profit Margin TOT 15.26
Income Statements
Revenue $40,890,959,352
Revenue Per Share $1,273.3080
Revenue 3 Years $5.70
Revenue 5 Years $6.53
Valuation Measures
PE Ratio 17.80
Enterprise Value $134,267,948,364
Price To Sales 0.031563
Price To Free Cash -39.9
PE High Last 5 Years 97.0
Price To Book 23.1
Price To Cash Flow 10.1
PE Low Last 5 Years 7.3
Price To Tangible Book -3.4
Financial Strength
Total Debt To Equity 9.3
Int Coverage 7.9
Current Ratio 0.7
Leverage Ratio 14.7
Quick Ratio 0.2
Long Term Debt To Capital 0.87
Assets
Receivables Turnover -
Invoice Turnover 1.80
Assets Turnover 0.50
Management Effectiveness
Return Assets 7.30
Return On Equity 121.40
Return On Capital 14.92
Dividends
Dividend 3 Years $-1.28
Dividend 5 Years $-4.64
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type Cash


Your Recent History
NYSE
GSK
GlaxoSmith..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.